Abeona Therapeutics Stock Technical Analysis
ABEO Stock | USD 3.41 3.95 53.67% |
As of the 24th of April, Abeona Therapeutics shows the risk adjusted performance of 0.0914, and Mean Deviation of 4.05. Abeona Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Abeona Therapeutics, which can be compared to its peers. Please confirm Abeona Therapeutics jensen alpha, and the relationship between the coefficient of variation and potential upside to decide if Abeona Therapeutics is priced correctly, providing market reflects its regular price of 3.41 per share. Given that Abeona Therapeutics has jensen alpha of 0.6055, we suggest you to validate Abeona Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Abeona Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Abeona, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AbeonaAbeona |
Abeona Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
20.5 | Strong Buy | 3 | Odds |
Most Abeona analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abeona stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abeona Therapeutics, talking to its executives and customers, or listening to Abeona conference calls.
Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Abeona Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Abeona Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Abeona Therapeutics Trend Analysis
Use this graph to draw trend lines for Abeona Therapeutics. You can use it to identify possible trend reversals for Abeona Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Abeona Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Abeona Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Abeona Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Abeona Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 70.09, which is the sum of squared deviations for the predicted Abeona Therapeutics price change compared to its average price change.About Abeona Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Abeona Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Abeona Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Abeona Therapeutics price pattern first instead of the macroeconomic environment surrounding Abeona Therapeutics. By analyzing Abeona Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Abeona Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Abeona Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Dividend Yield | 1.6K | 1.6K | Price To Sales Ratio | 30.6 | 29.07 |
Abeona Therapeutics April 24, 2024 Technical Indicators
Most technical analysis of Abeona help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Abeona from various momentum indicators to cycle indicators. When you analyze Abeona charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0914 | |||
Market Risk Adjusted Performance | 0.4442 | |||
Mean Deviation | 4.05 | |||
Semi Deviation | 4.28 | |||
Downside Deviation | 5.07 | |||
Coefficient Of Variation | 746.35 | |||
Standard Deviation | 5.6 | |||
Variance | 31.39 | |||
Information Ratio | 0.1181 | |||
Jensen Alpha | 0.6055 | |||
Total Risk Alpha | 0.0196 | |||
Sortino Ratio | 0.1305 | |||
Treynor Ratio | 0.4342 | |||
Maximum Drawdown | 36.43 | |||
Value At Risk | (6.12) | |||
Potential Upside | 8.32 | |||
Downside Variance | 25.67 | |||
Semi Variance | 18.35 | |||
Expected Short fall | (5.01) | |||
Skewness | 0.102 | |||
Kurtosis | 2.47 |
Abeona Therapeutics April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Abeona stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 1,180,383 | ||
Daily Balance Of Power | (4.34) | ||
Rate Of Daily Change | 0.46 | ||
Day Median Price | 3.80 | ||
Day Typical Price | 3.67 | ||
Price Action Indicator | (2.36) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Abeona Stock analysis
When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.53) | Revenue Per Share 0.164 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (2.61) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.